TrialDiabetes, obesity & metabolism2019

Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double-blind, randomized trial.

Hirotaka Watada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.